For example, in the “AML D1” case, Hi-C analysis detected a KMT2A::MLLT10 gene fusion (Figure 3A,B), while previous clinical testing comprising of karyotyping, FISH, short-read NGS, and microarray did not detect this clinically significant rearrangement. This evidence concerns the gene MLLT10 and acute myeloid leukemia.